Posted On: 04/21/2014 11:54:43 AM
Post# of 219
$SYN $2.70
called 12/10/13 $1.23
WebSite
10-K
3/31/14
O/S shares 58,276,556
'last' 10 trades
StockWatch
Nasdaq
Synthetic Biologics Appoints Mark Pimentel, M.D., Chairman of New Irritable Bowel Syndrome Clinical Advisory Board
4/14/2014 7:00:00 AM - PR Newswire
AmpliPhi Biosciences: A Speculative Play In Biopharmaceuticals Too Compelling To Ignore
4/11/2014 9:49:00 AM - Seeking Alpha
Are Tapeworms The Conceptual Key To The Next Multiple Sclerosis Blockbuster?
4/10/2014 11:06:00 AM - Seeking Alpha
Synthetic Biologics Q4 13 Earnings Conference Call At 10:00 AM ET
3/31/2014 9:00:00 AM - RTT News
Synthetic Biologics Reports Year End 2013 Financial Results and Operational Update
3/31/2014 7:00:00 AM - PR Newswire
StockMaven % Opinion
called 12/10/13 $1.23
WebSite
10-K
3/31/14
O/S shares 58,276,556
'last' 10 trades
StockWatch
Nasdaq
Synthetic Biologics Appoints Mark Pimentel, M.D., Chairman of New Irritable Bowel Syndrome Clinical Advisory Board
4/14/2014 7:00:00 AM - PR Newswire
AmpliPhi Biosciences: A Speculative Play In Biopharmaceuticals Too Compelling To Ignore
4/11/2014 9:49:00 AM - Seeking Alpha
Are Tapeworms The Conceptual Key To The Next Multiple Sclerosis Blockbuster?
4/10/2014 11:06:00 AM - Seeking Alpha
Synthetic Biologics Q4 13 Earnings Conference Call At 10:00 AM ET
3/31/2014 9:00:00 AM - RTT News
Synthetic Biologics Reports Year End 2013 Financial Results and Operational Update
3/31/2014 7:00:00 AM - PR Newswire
StockMaven % Opinion
(0)
(0)
